AU2002366192A1 - Derivatives of andrimide and moiramide b having antibacterial properties - Google Patents

Derivatives of andrimide and moiramide b having antibacterial properties

Info

Publication number
AU2002366192A1
AU2002366192A1 AU2002366192A AU2002366192A AU2002366192A1 AU 2002366192 A1 AU2002366192 A1 AU 2002366192A1 AU 2002366192 A AU2002366192 A AU 2002366192A AU 2002366192 A AU2002366192 A AU 2002366192A AU 2002366192 A1 AU2002366192 A1 AU 2002366192A1
Authority
AU
Australia
Prior art keywords
andrimide
moiramide
derivatives
antibacterial properties
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002366192A
Other languages
English (en)
Inventor
Nina Brunner
Christoph Freiberg
Thomas Lampe
Ben Newton
Michael Otteneder
Josef Pernerstorfer
Jens Pohlmann
Guido Schiffer
Mitsuyuki Shimada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002366192A1 publication Critical patent/AU2002366192A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AU2002366192A 2001-11-20 2002-11-07 Derivatives of andrimide and moiramide b having antibacterial properties Abandoned AU2002366192A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10156894A DE10156894A1 (de) 2001-11-20 2001-11-20 Harnstoffe
DE10156894.0 2001-11-20
PCT/EP2002/012428 WO2003043982A1 (de) 2001-11-20 2002-11-07 Derivate von andrimid und moiramid b mit antibakteriellen eigenschaften

Publications (1)

Publication Number Publication Date
AU2002366192A1 true AU2002366192A1 (en) 2003-06-10

Family

ID=7706325

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002366192A Abandoned AU2002366192A1 (en) 2001-11-20 2002-11-07 Derivatives of andrimide and moiramide b having antibacterial properties

Country Status (8)

Country Link
US (1) US7544709B2 (https=)
EP (1) EP1448521B1 (https=)
JP (1) JP4476626B2 (https=)
AU (1) AU2002366192A1 (https=)
CA (1) CA2467471C (https=)
DE (2) DE10156894A1 (https=)
ES (1) ES2250745T3 (https=)
WO (1) WO2003043982A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868203A (en) * 1986-06-02 1989-09-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Bacterial substance and pharmaceutical composition thereof
JPH01301657A (ja) * 1988-05-28 1989-12-05 Suntory Ltd 新規アンドリミド誘導体
JP2004501191A (ja) * 2000-06-28 2004-01-15 テバ　ファーマシューティカル　インダストリーズ　リミティド カルベジロール

Also Published As

Publication number Publication date
EP1448521B1 (de) 2005-09-28
DE50204419D1 (de) 2006-02-09
CA2467471A1 (en) 2003-05-30
EP1448521A1 (de) 2004-08-25
US7544709B2 (en) 2009-06-09
DE10156894A1 (de) 2003-05-28
US20050080129A1 (en) 2005-04-14
WO2003043982A1 (de) 2003-05-30
ES2250745T3 (es) 2006-04-16
JP4476626B2 (ja) 2010-06-09
JP2005514361A (ja) 2005-05-19
CA2467471C (en) 2011-05-10

Similar Documents

Publication Publication Date Title
AU2002363005A1 (en) Derivatives of uk-2a
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002335085A1 (en) Angiopoietins and methods of use thereof
AU2002314466A1 (en) Withasol and methods of use
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002351764A1 (en) Flavonoid compounds and their pharmaceutical uses
AU2002239933A1 (en) Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
AU2001257163A1 (en) Glycopeptide antibacterial compounds and methods of using same
AU2002304626A1 (en) Sterilization of surfaces
AU2002367969A1 (en) Toxin-phage bacteriocide antibiotic and uses thereof
AU2001286852A1 (en) Quinoline antibacterial compounds and methods of use thereof
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU2002346600A1 (en) 11-o-substituted macrolides and their descladinose derivatives
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2002366192A1 (en) Derivatives of andrimide and moiramide b having antibacterial properties
AU2001225523A1 (en) Novel arylpropionaldehyde derivatives and production and use of the same
AU2002251543A1 (en) Novel atisane compound and use thereof
AU2002355432A1 (en) Kavalactone compositions and methods of use
AU2002322247A1 (en) Antibacterial oxazinones and methods for their use and synthesis
AU2002354461A1 (en) Chitosanase and use thereof
AU2002307237A1 (en) Carboxybenzopyran derivatives and compositions
AU2002258842A1 (en) Hydrogenfluorides of aminosilanols and their use
AU2002242915A1 (en) Quinoline derivatives and their use as antibiotics
AU2002306336A1 (en) Novel isoxazolopyridone derivatives and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase